I

A

INNO , Alessandro

Last name: INNO

First name: Alessandro

2015 (v1)

Publication

Metadata-only

Pharmacokinetics of trastuzumab in haemodialysis

Gori, Stefania Foglietta, Jennifer Lunardi, Gianluigi

No description

Uploaded on: April 14, 2023
2018 (v1)

Publication

Metadata-only

PD-L1 Expression Heterogeneity in Non–Small Cell Lung Cancer: Defining Criteria for Harmonization between Biopsy Specimens and Whole Sections

Munari, Enrico Zamboni, Giuseppe Lunardi, Gianluigi

Introduction: Determination of programmed death ligand 1 (PD-L1) expression defines eligibility for treatment with pembrolizumab in patients with advanced NSCLC. This study was designed to better define which value across core biopsy specimens from the same case more closely reflects the PD-L1 expression status on whole sections and how many...

Uploaded on: March 27, 2023
2021 (v1)

Publication

Metadata-only

Differential influence of antibiotic therapy and other medications on oncological outcomes of patients with non-small cell lung cancer treated with first-line pembrolizumab versus cytotoxic chemotherapy

Cortellini, Alessio Di Maio, Massimo Nigro, Olga

Background: Some concomitant medications including antibiotics (ATB) have been reproducibly associated with worse survival following immune checkpoint inhibitors (ICIs) in unselected patients with non-small cell lung cancer (NSCLC) (according to programmed death-ligand 1 (PD-L1) expression and treatment line). Whether such relationship is...

Uploaded on: March 27, 2023